I did not have a chance to listen to the call, bec
Post# of 148167
I actually emailed him, through Quest Clinical Research. I asked him if he was still working with CytoDyn, and if he still believed in Leronlimab and CytoDyn, as I had a vote coming up, and just wanted to get a feel for where things were going.
To my surprise, or maybe not really a surprise, he emailed me back. He said that he was on the call, but let the others speak. He also said he is still CytoDyn’s scientific advisor, and said that he would be speaking on the next call. He went on to say that, nothing has changed. I obviously took that in meaning, that his beliefs have not changed.
Anyway, I voted yes on all 3 items. I continue to hope for the best. My largest investment is CytoDyn, and I did not want to vote no, and stifle management in this critical time. I do not know for certain what the future will hold, but I chose to say yes.